GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

It’s Official! Moderna’s COVID Vaccine Receives FDA Approval
2022-02-02
New Study Suggests Vaccines Protect against Long COVID
2022-01-28
Left, or Right? Orientation of Nanoparticles Influences Immune Response and Maturation
2022-01-25
UCB Strengthens Its Rare Disease Portfolio with Its Newest Acquisition
2022-01-20
Sema4 Buys GeneDx in Bid to Expand Genomic Database and Testing
2022-01-19
With A New Medical Device and Accompanying Platform, Roche Advances its Digital Ecosystem
2022-01-14
AstraZeneca’s Antibody Becomes the First Pre-exposure COVID-19 Treatment in the US
2021-12-09
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Aanika Bioscience Raises Fresh Capital to Scale Its Microbial “Tags” Technology Platform
2021-12-01
In a Blockbuster Day, Vaccibody Gets New Name and a Multi-Program Regeneron Deal to Boot
2021-11-24
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
Blackstone Chips in $250 Million to Aid Autolus’ CAR-T Therapy
2021-11-09
1 2 3 9
Scroll to Top